[1] WASSERMAN J D, URBAN S, FREEMAN M. A family of rhomboid-like genes:Drosophila rhomboid-1 and roughoid/rhomboid-3 cooperate to activate EGF receptor signaling[J]. Genes Develop, 2000, 14(13):1651-1663. [2] FREEMAN MATTHEW. Rhomboid proteases and their biological functions[J]. Ann Rev Genet, 2008, 42:191-210. [3] ADRAIN C, ZETTL M, CHRISTOVA Y, et al. Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE[J]. Science (New York), 2012, 335(6065):225-228. [4] SIGGS O M, XIAO NM, WANG Y, et al. iRhom2 is required for the secretion of mouse TNFα[J]. Blood, 2012, 119(24):5769-5771. [5] GOOZ M. ADAM-17:the enzyme that does it all[J]. Crit Rev Biochem Mol Biol, 2010, 45(2):146-169. [6] CHANTHAPHAVONG R S, LOUGHRAN P A, LEE T Y, et al. A role for cGMP in inducible nitric-oxide synthase (iNOS)-induced tumor necrosis factor (TNF) α-converting enzyme (TACE/ADAM17) activation, translocation, and TNF receptor 1(TNFR1) shedding in hepatocytes[J]. J Biol Chem, 2012, 287(43):35887-35898. [7] BERGBOLD N, LEMBERG M K. Emerging role of rhomboid family proteins in mammalian biology and disease[J]. Biochim Biophys Acta, 2013, 1828(12):2840-2848. [8] CHRISTOVA Y, ADRAIN C, BAMBROUGH P, et al. Mammalian iRhoms have distinct physiological functions including an essential role in TACE regulation[J].EMBO Rep, 2013, 14(10):884-890. [9] LEE M Y, NAM K H, CHOI K C. IRhoms,its functions and essential roles[J]. Biomol Therapeut, 2016, 24(2):109-114. [10] LEMBERG M K, ADRAIN C. Inactive rhomboid proteins:New mechanisms with implications in health and disease[J]. Semin Cell Dev Biol, 2016, 60:29-37. [11] CHENG C H, HUANG W, WEN H F, et al. iRhom2 promotes atherosclerosis through macrophage inflammation and induction of oxidative stress[J]. Biochem Biophys Res Commun, 2018, 503(3):1897-1904. [12] FREEMAN M. The rhomboid-like superfamily:molecular mechanisms and biological roles[J]. Ann Rev Cell Dev Biol, 2014, 30:235-254. [13] LI X, MARETZKY T, WESKAMP G, et al. iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling[J]. Proc Natl Acad Sci U S A, 2015, 112(19):6080-6085. [14] MANEY S K, MCILWAIN D R, POLZ R, et al. Deletions in the cytoplasmic domain of iRhom1 and iRhom2 promote shedding of the TNF receptor by the protease ADAM17[J]. Sci Signal, 2015, 8(401):ra109. [15] GROTH E,PRUESSMEYER J,BABENDREYER A, et al. Stimulated release and functional activity of surface expressed metalloproteinase ADAM17 in exosomes[J]. Biochim Biophys Acta, 2016, 1863(11):2795-2808. [16] CAVADAS M, OIKONOMIDI I, GASPAR C J, et al. Phosphorylation of irhom2 controls stimulated proteolytic shedding by the metalloprotease ADAM17/TACE[J]. Cell Rep, 2017, 21(3):745-757. [17] LI X, MARETZKY T, PEREZ-AGUILAR J M, et al. Structural modeling defines transmembrane residues in ADAM17 that are crucial for Rhbdf2-ADAM17-dependent proteolysis[J]. J Cell Sci, 2017, 130(5):868-878. [18] HOSUR V, FARLEY M L, BURZENSKI L M, et al. ADAM17 is essential for ectodomain shedding of the EGF-receptor ligand amphiregulin[J]. FEBS Open Biol, 2018, 8(4):702-710. [19] LICHTENTHALER S F, O'HARA B F, BLOBEL C P. iRhoms in the brain-a new frontier?[J]. Cell Cycle, 2015, 14(19):3003-3004. [20] DUSTERHOFT S, KUNZEL U, FREEMAN M. Rhomboid proteases in human disease:Mechanisms and future prospects[J]. Biochim Biophys Acta Mol Cell Res, 2017, 1864(11 PtB):2200-2209. [21] MCILWAIN DAVID R, LANG PHILIPP A, MARETZKY THORSTEN, et al. iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS[J]. Science (New York), 2012, 335(6065):229-232. [22] ISSUREE P D,MARETZKY T, MCILWAIN D R, et al. iRHOM2 is a critical pathogenic mediator of inflammatory arthritis[J]. J Clin Invest, 2013, 123(2):928-932. [23] LICHTENTHALER S F. iRHOM2 takes control of rheumatoid arthritis[J]. J Clin Invest, 2013, 123(2):560-562. |